Ikarian Capital, LLC Q2 2022 Filing

Filed August 12, 2022

Portfolio Value

$548.4M

Holdings

115

Report Date

Q2 2022

Filing Type

13F-HR

All Holdings (115 positions)

#	Stock	Shares	Value	% Portfolio	Type
101	MYMDMYMD PHARMACEUTICALS INC	81,089	$176K	0.03%
102	MBIOUSDMUSTANG BIO INC	246,824	$145K	0.03%
103	OVASUSDTEMPEST THERAPEUTICS INC	61,827	$132K	0.02%
104	—STEALTH BIOTHERAPEUTICS CORP	501,836	$127K	0.02%
105	—CYCLACEL PHARMACEUTICALS INC	104,741	$113K	0.02%
106	LRMRLARIMAR THERAPEUTICS INC	51,606	$100K	0.02%
107	IVAINVENTIVA SA	15,579	$93K	0.02%
108	DRUGBRIGHT MINDS BIOSCIENCES INC	105,958	$86K	0.02%
109	—MIND MEDICINE MINDMED INC	105,958	$68K	0.01%
110	OVIDOVID THERAPEUTICS INC	26,831	$59K	0.01%
111	—ENVERIC BIOSCIENCES INC	223,834	$48K	0.01%
112	—ALTAMIRA THERAPEUTICS LTD	75,000	$36K	0.01%
113	—BAUDAX BIO INC	2,966	$3K	0.00%
114	290ACHINOOK THERAPEUTICS INC	332,295	$0	0.00%
115	OTICEUROTONOMY INC	180	$0	0.00%

PreviousPage 2 of 2